Skip to main content

Fatty Acid Amide Hydrolase

  • Living reference work entry
  • First Online:
Encyclopedia of Signaling Molecules
  • 118 Accesses

Synonyms

Anandamide amidohydrolase; Oleamide hydrolase

Historical Background

A membrane-associated enzyme activity from rat liver that hydrolyzes N-acylethanolamine (NAE) species containing unsaturated and monounsaturated acyl chains was first described in 1985 by Schmid and colleagues (1985). Subsequently, an enzyme activity with similar properties that breaks the sleep-inducing substance cis-9-octadecenamide (oleamide) was reported and suggested to represent a general mechanism for terminating NAEs signaling in vivo. Nonetheless, the actual enzymes involved in NAEs metabolism remained unknown until the late 1990s, when Cravatt and colleagues purified this amidohydrolase activity from rat liver membranes (Cravatt et al. 1996). This enzyme, named fatty acid amide hydrolase (FAAH; E.C. 3.5.1.4), was shown to be specifically inhibitable (Deutsch et al. 1997), was recombinantly expressed, and was found to hydrolyze several endogenous NAEs, including the neuromodulator/neurotransmitter N-a...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  • Ando T, Tamura N, Mera T, Morita C, Takei M, Nakamoto C, Koide M, Hotta M, Naruo T, Kawai K, Nakahara T, Yamaguchi C, Nagata T, Ookuma K, Okamoto Y, Yamanaka T, Kiriike N, Ichimaru Y, Ishikawa T, Komaki G, Japanese Genetic Research Group For Eating Disorders. Association of the c.385C>A (p.Pro129Thr) polymorphism of the fatty acid amide hydrolase gene with anorexia nervosa in the Japanese population. Mol Genet Genomic Med. 2014;2:313–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bari M, Battista N, Valenza M, Mastrangelo N, Malaponti M, Catanzaro G, Centonze D, Finazzi-Agrò A, Cattaneo E, Maccarrone M. In vitro and in vivo models of Huntington’s disease show alterations in the endocannabinoid system. FEBS J. 2013;280:3376–3388.

    Article  CAS  PubMed  Google Scholar 

  • Bisogno T, Maccarrone M. Latest advances in the discovery of fatty acid amide hydrolase inhibitors. Expert Opin Drug Discov. 2013;8:509–22.

    Article  CAS  PubMed  Google Scholar 

  • Blankman JL, Cravatt BF. Chemical probes of endocannabinoid metabolism. Pharmacol Rev. 2013;65:849–71.

    Article  PubMed  PubMed Central  Google Scholar 

  • Bracey MH, Hanson MA, Masuda KR, Stevens RC, Cravatt BF. Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling. Science. 2002;298:1793–6.

    Article  CAS  PubMed  Google Scholar 

  • Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature. 1996;384:83–7.

    Article  CAS  PubMed  Google Scholar 

  • Dainese E, De Fabritiis G, Sabatucci A, Oddi S, Angelucci CB, Di Pancrazio C, Giorgino T, Stanley N, Del Carlo M, Cravatt BF, Maccarrone M. Membrane lipids are key modulators of the endocannabinoid-hydrolase FAAH. Biochem J. 2014;457:463–72.

    Article  CAS  PubMed  Google Scholar 

  • Deutsch DG, Omeir R, Arreaza G, Salehani D, Prestwich GD, Huang Z, Howlett A. Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase. Biochem Pharmacol. 1997;53:255–60.

    Article  CAS  PubMed  Google Scholar 

  • Fernández-Ruiz J, Romero J, Ramos JA. Endocannabinoids and neurodegenerative disorders: Parkinson’s disease, Huntington’s chorea, Alzheimer’s disease, and others. Handb Exp Pharmacol. 2015;231:233–59.

    Article  PubMed  Google Scholar 

  • Fezza F, De Simone C, Amadio D, Maccarrone M. Fatty acid amide hydrolase: a gate-keeper of the endocannabinoid system. Subcell Biochem. 2008;49:101–32.

    Article  PubMed  Google Scholar 

  • Fowler CJ. The potential of inhibitors of endocannabinoid metabolism for drug development: a critical review. Handb Exp Pharmacol. 2015;23:95–128.

    Article  Google Scholar 

  • Grimaldi P, Pucci M, Di Siena S, Di Giacomo D, Pirazzi V, Geremia R, Maccarrone M. The faah gene is the first direct target of estrogen in the testis: role of histone demethylase LSD1. Cell Mol Life Sci. 2012;69:4177–90.

    Article  CAS  PubMed  Google Scholar 

  • Hansson AC, Bermúdez-Silva FJ, Malinen H, Hyytiä P, Sanchez-Vera I, Rimondini R, Rodriguez de Fonseca F, Kunos G, Sommer WH, Heilig M. Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference. Neuropsychopharmacology. 2007;32:117–26.

    Article  CAS  PubMed  Google Scholar 

  • Lazary J, Eszlari N, Juhasz G, Bagdy G. Genetically reduced FAAH activity may be a risk for the development of anxiety and depression in persons with repetitive childhood trauma. Eur Neuropsychopharmacol. 2016;26:1020–8.

    Article  CAS  PubMed  Google Scholar 

  • Maccarrone M, Bab I, Bíró T, Cabral GA, Dey SK, Di Marzo V, Konje JC, Kunos G, Mechoulam R, Pacher P, Sharkey KA, Zimmer A. Endocannabinoid signaling at the periphery: 50 years after THC. Trends Pharmacol Sci. 2015;36:277–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Marco EM, Rapino C, Caprioli A, Borsini F, Laviola G, Maccarrone M. Potential therapeutic value of a novel FAAH inhibitor for the treatment of anxiety. PLoS ONE. 2015;10:e0137034.

    Article  PubMed  PubMed Central  Google Scholar 

  • Mileni M, Johnson DS, Wang Z, Everdeen DS, Liimatta M, Pabst B, Bhattacharya K, Nugent RA, Kamtekar S, Cravatt BF, Ahn K, Stevens RC. Structure-guided inhibitor design for human FAAH by interspecies active site conversion. Proc Natl Acad Sci U S A. 2008;105:12820–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pertwee R.G. Endocannabinoids and Their Pharmacological Actions. In: Handb Exp Pharmacol. Springer. 2015;231:1–37. doi 10.1007/978-3-319-20825-1.

    Google Scholar 

  • Schmid PC, Zuzarte-Augustin ML, Schmid HH. Properties of rat liver N-acylethanolamine amidohydrolase. J Biol Chem. 1985;260:14145–9.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mauro Maccarrone .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media LLC

About this entry

Cite this entry

Fezza, F., Bari, M., Fazio, D., Maccarrone, M. (2016). Fatty Acid Amide Hydrolase. In: Choi, S. (eds) Encyclopedia of Signaling Molecules. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6438-9_101566-1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-6438-9_101566-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, New York, NY

  • Online ISBN: 978-1-4614-6438-9

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics